Abstract: The present invention relates to an association of a Vichy thermal water and an extract of at least one bacterium from the species Vitreoscilla filiformis cultured on a medium comprising at least one Vichy thermal water, to a composition comprising said association, to a cosmetic treatment process comprising the application to keratin materials of said cosmetic composition for caring for keratin materials, in particular the skin; and also to the cosmetic use of said association for caring for keratin materials, in particular the skin.

Abstract: The present invention relates to a cosmetic composition for topical application, comprising, in a physiologically acceptable medium: at least one oligosaccharide and/or polysaccharide, selected from the group consisting of inulins, fructooligosaccharides, glucooligosaccharides, soya-derived oligosaccharides, pyrodextrins, isomaltooligosaccharides, xylooligosaccharides, transgalactooligosaccharides and mixtures thereof, and at least one mannose monosaccharide. The present invention also concerns a method of cosmetic treatment for caring for the skin and/or mucous membranes, which comprises the application to the skin and/or the mucous membranes, in particular having undergone external aggression, of said composition; and also concerns cosmetic uses thereof.

Abstract: Cosmetic use of an effective amount of a lysate of at least one microorganism of the genus Bifidobacterium species and/or one of its fractions in treating and/or preventing dryness and/or associated disorders of a keratinous substance.

Abstract: The invention relates to the cosmetic use of an effective amount of at least one monounsaturated fatty acid, of a salt thereof and/or of an ester thereof, as a nailcare active agent.

Abstract: The present invention relates to the topical use of Bifidobacterium longum subsp. longum CNCM I-2618, as a pro-pigmenting agent, in particular in the prevention and/or treatment of alterations of skin and/or hair color homogeneity and for creating a uniform complexion.

Abstract: Cosmetic use of an effective amount of at least one lysate of at least one microorganism of the genus Bifidobacterium species and/or a fraction thereof, for preventing and/or treating a skin disorder in the case of sensitive skin.

Abstract: Cosmetic use of an effective amount of a lysate of at least one microorganism of the genus Bifidobacterium species and/or one of its fractions in treating and/or preventing dryness and/or associated disorders of a keratinous substance.

Abstract: Provided is a cosmetic method by topical route for treating and/or preventing unpleasant human body odours, which comprises applying, to the surface of a human keratinous substance, a composition comprising, in a physiologically acceptable medium, at least one monounsaturated fatty acid or one of its salts and/or one of its esters and/or one of its amides. Also provided is a cosmetic method by the oral route for treating and/or preventing unpleasant human body odours, comprising ingesting an oral composition comprising, in a physiologically acceptable medium, at least one monounsaturated fatty acid or one of its salts and/or one of its esters and/or one of its amides.

Abstract: The present invention relates to the cosmetic treatment of greasy skin and/or skin that tends to be greasy with a lysate of at least one microorganism of the genus Bifidobacterium species and/or a fraction thereof, as an active.

Abstract: Red blotches on the skin such as those associated with environmental stresses, or red blotches associated with a skin disorder, for example those occurring during rosacea, are treated/reduced by administering to individuals afflicted therewith, thus effective amounts of at least one extract of a non-photosynthetic and non-fruiting filamentous bacterium cultured in a medium which includes at least one non-sulfurous mineral and/or thermal water, e.g., an extract derived from the bacterium Vitreoscilla filiformis, in particular the strain ATCC 15551, cultured in a medium enriched with water from La Roche Posay.

Abstract: The invention relates to the oral or nutraceutical cosmetic use of an effective amount of at least one monounsaturated fatty acid, a salt thereof and/or an ester thereof, as an active agent for treating and/or preventing skin complexion imperfections.

Abstract: The invention relates to the cosmetic use, by oral administration, of a combination of active agents including at least petroselinic acid and at least one active agent selected from among taurine, arginine, cysteine, zinc, a salt thereof, and lycopene, for improving the quality of nails, specifically the microvascularization of the nails, in particular in pre-hypertensive individuals.

Abstract: Cosmetic or therapeutic, in particular dermatological, use of dermicidin, or analogues or fragments thereof, for preventing the appearance of imperfections, and also for the treatment and diagnosis of acneic skin or acne-prone skin. The subject matter of the present invention is in particular the use of a cosmetic and/or therapeutic, in particular dermatological, composition containing at least one amino acid sequence of dermicidin, or of an analogue or fragment thereof, or of at least one nucleic acid sequence encoding the sequence, for preventing the appearance of imperfections, and also for the treatment and/or prevention and/or diagnosis of acneic and/or oily or acne-prone and/or oily skin. It also related to a method for applying the abovementioned cosmetic composition for the prevention of the appearance of imperfections and the treatment of acne-prone and/or oily skin.

Abstract: Bags and/or dark circles around the eyes of individuals afflicted therewith are reduced by administering to such individuals thus effective amounts of at least one extract of a non-photosynthetic and non-fruiting filamentous bacterium cultured in a medium which includes at least one non-sulfurous mineral and/or thermal water, e.g., an extract derived from the bacterium Vitreoscilla filiformis, in particular the strain ATCC 15551, cultured in a medium enriched with water from La Roche Posay.

Abstract: The present invention relates to the field of weight management and obesity. It concerns petroselinic acid or a combination of active ingredients including at least petroselinic acid and at least one compound chosen from zinc, taurine, one of the salts of same, lycopene and the mixtures thereof, and preferably at least taurine or zinc gluconate and, more preferably still, at least taurine and zinc gluconate, as a drug for oral administration or as a functional food intended to promote weight loss and/or weight maintenance in a human being and/or animal, or indeed intended to fight obesity.

Abstract: The invention relates to the cosmetic use, by oral administration, of a combination of active agents including at least petroselinic acid and at least one active agent selected from among taurine, arginine, cysteine, zinc, a salt thereof, and lycopene, for improving the quality of nails, specifically the microvascularization of the nails, in particular in pre-hypertensive individuals.

Abstract: The invention relates to the cosmetic use, by oral administration, of a combination of active agents including petroselinic acid and taurine, for improving hair quality and for preventing and controlling the microinflammation of hair follicles, in particular for controlling hair aging in men over the age of 30 or in women.

Abstract: The present invention concerns the cosmetic use, by oral administration, of petroselinic acid or of a combination of active ingredients comprising at least petroselinic acid and at least one compound chosen from zinc, taurine, one of the salts of same, lycopene and the mixtures thereof, and preferably at least taurine or zinc gluconate and, more preferably still, at least taurine and zinc gluconate, with the aim of fighting against aesthetic disorders of the body figure linked to modifications in the adipose tissue.

Abstract: The present invention relates to a use of an effective amount of at least one probiotic microorganism and/or a fraction thereof and/or a metabolite thereof for preventing and/or treating dandruff disorders of the scalp, as well as a cosmetic process for preventing and/or treating a dandruff condition including the administration a first cosmetic active agent and of at least a second cosmetic active agent, topically, the said first and second cosmetic active agents being formulated in separate compositions, the first cosmetic active agent being chosen from probiotic microorganisms, and mixtures thereof, and the second cosmetic active agent being chosen from antidandruff active agents.

Abstract: The present invention relates to the topical use of Bifidobacterium longum subsp. longum CNCM I-2618, as a pro-pigmenting agent, in particular in the prevention and/or treatment of alterations of skin and/or hair color homogeneity and for creating a uniform complexion.